Solid oral forms availability in children: A cost saving investigation

British Journal of Clinical Pharmacology

Volumn 78, Issue 5, 2014, Pages 1080-1089

  Lajoinie, Audrey ^a,b   Henin, Emilie ^a,b   Kassai, Behrouz ^b   Terry, David ^c,d  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d ASTON UNIVERSITY   (United Kingdom)

Author keywords

Drug formulation; Oral drug delivery; Paediatric; Swallowing

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CODEINE; COLECALCIFEROL; EXCIPIENT; IBUPROFEN; LACTULOSE; OMEPRAZOLE; ONDANSETRON; PARACETAMOL; PENICILLIN V; RANITIDINE; PRESCRIPTION DRUG; TABLET;

ARTICLE; CHILD; COST BENEFIT ANALYSIS; COST CONTROL; CROSS-SECTIONAL STUDY; DRUG CAPSULE; DRUG FORMULATION; HUMAN; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; OBSERVATIONAL STUDY; PHARMACY; PRESCRIPTION; SHORT COURSE THERAPY; STOMATOLOGY; TABLET; UNITED KINGDOM; UNLICENSED DRUG USE; ADMINISTRATION AND DOSAGE; ADOLESCENT; DRUG COST; ECONOMICS; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; PATIENT PREFERENCE; PRESCHOOL CHILD; SUPPLY AND DISTRIBUTION;

ADMINISTRATION, ORAL; ADOLESCENT; CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; COST SAVINGS; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DRUG COSTS; GREAT BRITAIN; HUMANS; PATIENT PREFERENCE; PRESCRIPTION DRUGS; TABLETS;

EID: 84916916145     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12442     Document Type: Article

References (46)

1. Salunke S, Hempenstall J, Kendall R, Roger B, Mroz C, Nunn T, Tuleu C. European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary-Formulating better medicines for children. Int J Pharm 2011; 419: 235-9.
2. European Medicines Agency, Committee for Medicinal Products for Human Use. Reflection paper: formulations of choice for the paediatric population, 2006; EMEA/CHMP/PEG/194810/2005.
3. Walsh J, Mills S. Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference. Ther Deliv 2013; 4: 21-5.
4. Cram A, Breitkreutz J, Desset-Brethes S, Nunn T, Tuleu C, European Paediatric Formulation I. Challenges of developing palatable oral paediatric formulations. Int J Pharm 2009; 365: 1-3.
5. Nahata MC. Lack of pediatric drug formulations. Pediatrics 1999; 104: 607-9.
6. Schirm E, Tobi H, de Vries TW, Choonara I, De Jong-van den Berg LT. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr 2003; 92: 1486-9.
7. World Health Organization. Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children. Geneva: WHO Headquarters, 2009.
8. Yeung VW, Wong IC. When do children convert from liquid antiretroviral to solid formulations?. Pharm World Sci 2005; 27: 399-402.
9. Yin HS, Mendelsohn AL, Wolf MS, Parker RM, Fierman A, van Schaick L, Bazan IS, Kline MD, Dreyer BP. Parents' medication administration errors: role of dosing instruments and health literacy. Arch Pediatr Adolesc Med 2010; 164: 181-6.
10. Bailey SC, Pandit AU, Yin S, Federman A, Davis TC, Parker RM, Wolf MS. Predictors of misunderstanding pediatric liquid medication instructions. Fam Med 2009; 41: 715-21.
11. Schillie SF, Shehab N, Thomas KE, Budnitz DS. Medication overdoses leading to emergency department visits among children. Am J Prev Med 2009; 37: 181-7.
12. European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline on pharmaceutical development of medicines for paediatric use. 2013; EMA/CHMP/QWP/805880/2012 Rev. 2.
13. French National Agency for Medicines and Health Products Safety (ANSM). Management of Medication Errors Associated with the Use of Delivery Devices for Orally Ingested Liquid Drugs. Available at http://ansm.sante.fr/var/ansm-site/storage/original/application/202d871e1 bdcead7004ad0d7b07e2f4d.pdf (last accessed 2 August 2014).
14. Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol 2005; 59: 674-6.
15. Ansah EK, Gyapong JO, Agyepong IA, Evans DB. Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup. Trop Med Int Health 2001; 6: 496-504.
16. Bagenda A, Barlow-Mosha L, Bagenda D, Sakwa R, Fowler MG, Musoke PM. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda. Ann Trop Paediatr 2011; 31: 235-45.
17. Garvie PA, Lensing S, Rai SN. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Pediatrics 2007; 119: e893-9.
18. Spomer N, Klingmann V, Stoltenberg I, Lerch C, Meissner T, Breitkreutz J. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study. Arch Dis Child 2012; 97: 283-6.
19. Thomson SA, Tuleu C, Wong IC, Keady S, Pitt KG, Sutcliffe AG. Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics 2009; 123: e235-8.
20. Standing JF, Tuleu C. Paediatric formulations-getting to the heart of the problem. Int J Pharm 2005; 300: 56-66.
21. Sam T, Ernest TB, Walsh J, Williams JL, European Paediatric Formulation I. A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms-an application for paediatric dosage form selection. Int J Pharm 2012; 435: 115-23.
22. Walsh KE, Mazor KM, Stille CJ, Torres I, Wagner JL, Moretti J, Chysna K, Stine CD, Usmani GN, Gurwitz JH. Medication errors in the homes of children with chronic conditions. Arch Dis Child 2011; 96: 581-6.
23. European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline on pharmaceutical development of medicines for paediatric use. 2011; EMA/CHMP/QWP/180157/2011.
24. Van Riet-Nales DA, de Neef BJ, Schobben AF, Ferreira JA, Egberts TC, Rademaker CM. Acceptability of different oral formulations in infants and preschool children. Arch Dis Child 2013; 98: 725-31.
25. Ameen VZ, Pobiner BF, Giguere GC, Carter EG. Ranitidine (Zantac) syrup versus ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study. Paediatr Drugs 2006; 8: 265-70.
26. Chappuy H, Patteau G, Treluyer JM, Cheron G. Medications dosage and adherence. Arch Pediatr 2009; 16: 968-9.
27. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984; 6: 592-9.
28. Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, Alex R, Hempenstall J. Preparation of medicines for children-a hierarchy of classification. Int J Pharm 2012; 435: 124-30.
29. Fontan JE, Mille F, Brion F, Aubin F, Ballereau F, Benoit G, Brunet ML, Braguier D, Combeau D, Dugast P, Gerout AC, May I, Meunier P, Naveau-Ploux C, Proust V, Samdjee F, Schlatter J, Thebault A, Vie M, Groupe Pediatrie de la Societe Francaise de Pharmacie C. [Drug administration to paediatric inpatient]. Arch Pediatr 2004; 11: 1173-84.
30. Richey RH, Shah UU, Peak M, Craig JV, Ford JL, Barker CE, Nunn AJ, Turner MA. Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC Pediatr 2013; 13: 81.
31. Quinzler R, Gasse C, Schneider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol 2006; 62: 1065-73.
32. McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacotherapy 1998; 18: 193-7.
33. Van Santen E, Barends DM, Frijlink HW. Breaking of scored tablets: a review. Eur J Pharm Biopharm 2002; 53: 139-45.
34. Habib MA, Soofi SB, Bhutta ZA. Effect of zinc in tablet and suspension formulations in the treatment of acute diarrhoea among young children in an emergency setting of earthquake affected region of Pakistan. J Coll Physicians Surg Pak 2010; 20: 837-8.
35. Shah RB, Collier JS, Sayeed VA, Bryant A, Habib MJ, Khan MA. Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium. AAPS PharmSciTech 2010; 11: 1359-67.
36. Rodenhuis N, De Smet PA, Barends DM. The rationale of scored tablets as dosage form. Eur J Pharm Sci 2004; 21: 305-8.
37. Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int J Pharm 2011; 404: 1-9.
38. Czyzewski DI, Runyan RD, Lopez MA, Calles NR. Teaching and maintaining pill-swallowing in HIV-infected children. AIDS Read 2000; 10: 88-95.
39. Cruz-Arrieta E. Pill-swallowing training: a brief pediatric oncology report. Prim Psychiatry 2008; 15: 49-53.
40. Wright L, Woodcock JM, Scott R. Conditioning children when refusal of oral medication is life threatening. Pediatrics 1969; 44: 969-72.
41. Dahlquist LM, Blount RL. Teaching a six-year-old girl to swallow pills. J Behav Ther Exp Psychiatry 1984; 15: 171-3.
42. Blount RL, Dahlquist LM, Baer RA, Wuori D. A brief, effective method for teaching children to swallow pills. Behav Ther 1984; 15: 381-7.
43. Walco GA. A behavioral treatment for difficulty in swallowing pills. J Behav Ther Exp Psychiatry 1986; 17: 127-8.
44. Pelco LE, Kissel RC, Parrish JM, Miltenberger RG. Behavioral management of oral medication administration difficulties among children: a review of literature with case illustrations. J Dev Behav Pediatr 1987; 8: 90-6.
45. Babbitt RL, Parrish JM, Brierley PE, Kohr MA. Teaching developmentally disabled children with chronic illness to swallow prescribed capsules. J Dev Behav Pediatr 1991; 12: 229-35.
46. Sallows GO. Behavioral treatment of swallowing difficulty. J Behav Ther Exp Psychiatry 1980; 11: 45-7.